"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009)

"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009) mistakenly said that biotech company Celgene has a forthcoming treatment for hepatitis C. Celgene is not focusing on this disease.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE